摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diethyl N-(4-nitrobenzoyl)-L-aspartate | 27128-94-5

中文名称
——
中文别名
——
英文名称
diethyl N-(4-nitrobenzoyl)-L-aspartate
英文别名
Diaethyl-N-(p-nitrobenzoyl)-L-asparginat;diethyl (2S)-2-[(4-nitrobenzoyl)amino]butanedioate
diethyl N-(4-nitrobenzoyl)-L-aspartate化学式
CAS
27128-94-5
化学式
C15H18N2O7
mdl
——
分子量
338.317
InChiKey
CFUWWCWIAUTJHP-LBPRGKRZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    24
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    128
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    diethyl N-(4-nitrobenzoyl)-L-aspartate 在 palladium on activated charcoal 2,6-二甲基吡啶氢气calcium carbonate 作用下, 以 乙醇 为溶剂, 25.0 ℃ 、101.33 kPa 条件下, 反应 144.0h, 生成 diethyl N-<4-prop-2-ynylamino>benzoyl>-L-aspartate
    参考文献:
    名称:
    Quinazoline antifolates inhibiting thymidylate synthase. Variation of the amino acid
    摘要:
    Five new analogues (1c-g) of the antifolate N10-propargyl-5,8-dideazafolic acid (1a) are described in which the benzoyl-L-glutamate moiety was replaced by benzoic acid (desglutamyl-N10-propargyl-5,8-dideazafolic acid), benzoyl-L-aspartate, 4-phenylbutyrate, benzoylglycine, and benzoyl-L-alanine. The esters of the appropriate 4-aminophenyl (benzoyl) starting materials were sequentially alkylated upon nitrogen, first with a propargyl halide and then with 2-amino-6-(bromomethyl)-4-hydroxyquinazoline hydrobromide. Saponification of the antifolate esters so produced gave the desired analogues. The new derivatives (1c-g) and also the known diethyl ester of 1a (1b) were tested for their inhibition of purified L1210 thymidylate synthase (TS) and for their inhibition of the growth of L1210 cells in culture. The TS inhibition of the analogues 1b-g was estimated by calculating the inverse relative potency, defined as the ratio IC50(compound)/IC50(1a). The results obtained were as follows: greater than 62, 84, 9, 333, 21, and 5, respectively. All were thus less inhibitory than 1a. None of the compounds improved upon 1a in inhibiting the growth of L1210 cells in culture.
    DOI:
    10.1021/jm00156a033
  • 作为产物:
    描述:
    4-硝基苯甲酰氯diethyl L-aspartate hydrochloride吡啶 作用下, 以 甲苯 为溶剂, 以53%的产率得到diethyl N-(4-nitrobenzoyl)-L-aspartate
    参考文献:
    名称:
    Quinazoline antifolates inhibiting thymidylate synthase. Variation of the amino acid
    摘要:
    Five new analogues (1c-g) of the antifolate N10-propargyl-5,8-dideazafolic acid (1a) are described in which the benzoyl-L-glutamate moiety was replaced by benzoic acid (desglutamyl-N10-propargyl-5,8-dideazafolic acid), benzoyl-L-aspartate, 4-phenylbutyrate, benzoylglycine, and benzoyl-L-alanine. The esters of the appropriate 4-aminophenyl (benzoyl) starting materials were sequentially alkylated upon nitrogen, first with a propargyl halide and then with 2-amino-6-(bromomethyl)-4-hydroxyquinazoline hydrobromide. Saponification of the antifolate esters so produced gave the desired analogues. The new derivatives (1c-g) and also the known diethyl ester of 1a (1b) were tested for their inhibition of purified L1210 thymidylate synthase (TS) and for their inhibition of the growth of L1210 cells in culture. The TS inhibition of the analogues 1b-g was estimated by calculating the inverse relative potency, defined as the ratio IC50(compound)/IC50(1a). The results obtained were as follows: greater than 62, 84, 9, 333, 21, and 5, respectively. All were thus less inhibitory than 1a. None of the compounds improved upon 1a in inhibiting the growth of L1210 cells in culture.
    DOI:
    10.1021/jm00156a033
点击查看最新优质反应信息

文献信息

  • Quinazoline analogues of folic acid
    作者:J. Davoll、A. M. Johnson
    DOI:10.1039/j39700000997
    日期:——
    Analogues of folic acid having the pteridine ring replaced by quinazoline have been prepared by reductive condensation of appropriately substituted quinazoline-6-carbaldehydes and -carbonitriles with diesters of N-(p-aminobenzoyl) amino-acids, followed by hydrolysis.
    通过将适当取代的喹唑啉-6-甲醛和-腈与N-(对基苯甲酰基)氨基酸的二酯进行还原性缩合反应,制备了具有被喹唑啉取代的蝶啶环的叶酸的类似物。
  • Ligands for metal affinity chromatography
    申请人:——
    公开号:US20020019496A1
    公开(公告)日:2002-02-14
    The invention provides a metal chelate resin that comprises repeating units having the structure: 1 where M is a metal ion in an oxidation state capable of forming a complex with a tetradentate ligand having an overall coordination number of at least 6, R1, R2, R3, R4 and R5 are each hydrogen, halogen, straight-chain or branched alkyl, or alkenyl having 1 to 4 carbon atoms, halogenoalkyl having 1 or 2 carbon atoms and 1 to 5 fluorine, chlorine and/or bromine atoms, straight-chain or branched alkoxyalkyl having 1 to 3 carbon atoms in the alkoxy moiety and 1 to 3 carbon atoms in the alkyl moiety, alkylcarbonyl having 1 to 4 carbon atoms in the straight-chain or branched alkyl moiety, phenyl, or phenylcarbonyl, it being possible for each of the above mentioned phenyl radicals to be mono- to tri-substituted by identical or different substituents from the group consisting of fluorine, chlorine, bromine, cyano, nitro, alkyl having 1 or 2 carbon atoms, alkoxy having 1 or 2 carbon atoms, alkylthio having 1 or 2 carbon atoms, halogenoalkyl having 1 or 2 carbon atoms and 1 to 5 fluorine, chlorine and/or bromine atoms, halogenoalkoxy having 1 or 2 carbon atoms and 1 to 5 fluorine, chlorine and/or bromine atoms, halogenoalkylthio having 1 or 2 carbon atoms and 1 to 5 fluorine, chlorine and/or bromine atoms, provided that if R2, R3, R4 and R5 are all hydrogen R1 may not be hydrogen, R6 is a linking arm connecting the nitrogen atom of the ligand with R7 where R7 is a functional linking group through which the R6 linking arm is connected to R8 and R8 is an insoluble immobilization matix.
    本发明提供了一种属螯合树脂,它由具有以下结构的重复单元组成: 1 其中 M 是处于氧化态的属离子,能与总配位数至少为 6 的四价配体形成络合物,R1、R2、R3、R4 和 R5 分别是氢、卤素、直链或支链烷基或具有 1 至 4 个碳原子的烯基、具有 1 或 2 个碳原子和 1 至 5 个和/或溴原子的卤代烷基、在直链或支链烷基中具有 1 至 3 个碳原子的直链或支链烷氧基烷基和具有 1 至 3 个碳原子的烷基、在直链或支链烷基中具有 1 至 4 个碳原子的烷基羰基、苯基或苯基羰基,上述每个苯基都可以被由组成的组中相同或不同的取代基单取代或三取代、基、硝基、具有 1 或 2 个碳原子的烷基、具有 1 或 2 个碳原子的烷氧基、具有 1 或 2 个碳原子的烷基、具有 1 或 2 个碳原子和 1 至 5 个和/或溴原子的卤代烷基、具有 1 或 2 个碳原子和 1 至 5 个和/或溴原子的卤代烷氧基、具有 1 或 2 个碳原子和 1 至 5 个和/或溴原子的卤代烷基,条件是如果 R2、R3、R4 和 R5 都是氢,R1 可能不是氢,R6 是连接配体的氮原子与 R7 的连接臂,其中 R7 是官能连接基团,R6 连接臂通过该官能连接基团与 R8 连接,R8 是不溶性固定基团。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸